Edward Myles, CFO and EVP of Corp. Dev. at Ocata Therapeutics, holds 98.66K shares in Amag Pharmaceuticals (Ticker: AMAG), holds 0.00 shares in Ocata Therapeutics (Ticker: OCAT), holds ― shares in Scholar Rock Holding (Ticker: SRRK).
What is the percentage of profitable transactions made by Edward Myles?
The percentage of profitable transactions made by Edward Myles is ―.
What is the average return per transaction made by Edward Myles?
The average return per transaction made by Edward Myles is ―.
What stocks does Edward Myles hold?
Edward Myles holds: OCAT, AMAG, SRRK, PBIO stocks.
What was Edward Myles’s latest transaction?
Edward Myles latest transaction was an Uninformative Buy of ―.
What was Edward Myles's most profitable transaction?
Edward Myles’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Edward Myles's role in Ocata Therapeutics?
Edward Myles's role in Ocata Therapeutics is CFO and EVP of Corp. Dev..
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.